Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bourne Partners Strategic Capital (BPSC) is a private equity firm specializing in middle-market investments within the pharmaceutical, pharma services, and consumer healthcare sectors. Headquartered in Charlotte, North Carolina, the firm leverages over 20 years of experience as both owners and operators to drive growth and value creation in its portfolio companies. BPSC focuses on operationally intensive, control-oriented investments, often partnering with management teams to enhance performance through strategic sourcing, operational solutions, and long-term capital support. The firm's portfolio includes notable companies such as Covis Pharma, Tanner Pharma Group, and Pharmaceutical Associates, Inc. (PAI), reflecting its commitment to improving global health outcomes through disciplined capital allocation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Strategic Capital.